Antisense Drug Slashed Hereditary Angioedema Attacks in Small Study
(MedPage Today) -- Patients with hereditary angioedema who were treated with an antisense oligonucleotide treatment, donidalorsen, experienced significantly fewer attacks than patients who received placebo, a phase II trial showed.
Over 17 weeks...
Source: MedPage Today Allergy - Category: Allergy & Immunology Source Type: news